Literature DB >> 8335520

The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model.

S Gudmundsson1, S Einarsson, H Erlendsdottir, J Moffat, W Bayer, W A Craig.   

Abstract

The post-antibiotic effect (PAE) may allow for more widely spaced dosing of antibiotics than is currently employed without loss of efficacy. Antimicrobial combinations are widely used in clinical medicine. However, dosing schedules are usually based on pharmacological profiles of the drugs used alone. Previously we have demonstrated significant prolongation of the PAE induced by antimicrobial combinations in vitro as compared to PAEs induced by the agents alone. We examined this issue further in vivo in a neutropenic mouse thigh infection model, by exposing Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Klebsiella pneumoniae to several antimicrobials, either singly or in combination. The PAE in vivo was defined as the difference in time needed for the organisms in the treated animals to grow 1 log10 as compared with controls after serum drug concentrations had fallen below the MIC. Drug concentrations exceeded the MIC for 1.2-3.2 h, but bactericidal activity occurred mainly during the first hour. When the agents were used singly a negative PAE was produced by ceftazidime against P. aeruginosa, a PAE of approximately 0 h by imipenem against E. coli and K. pneumoniae, a PAE of 2-4 h by cefazolin against S. aureus, gentamicin against E. coli and K. pneumoniae, and imipenem and tobramycin against P. aeruginosa, and a PAE of 6-7 h by gentamicin against S. aureus and rifampicin against P. aeruginosa. The beta-lactam/aminoglycoside combinations when used against S. aureus and P. aeruginosa prolonged the PAE by 1.0-3.3 h, compared with the longer of the individual drug PAEs, but no prolongation was observed against E. coli and K. pneumoniae. Ceftazidime reduced the PAE when used with tobramycin against P. aeruginosa. The long PAE of rifampicin against P. aeruginosa was 'carried over' to the combination, thus prolonging the growth suppression achieved by imipenem and tobramycin alone or in combination by 5.5-8.0 h. This effect on the PAE was additive only, and synergy was not observed. In conclusion, a potentially significant prolongation of the PAE by combination of drugs was observed in vivo, but only if both (or all) agents induced a PAE when used alone. The impact of this observation needs to be examined further in studies involving multiple and different dosing regimens in an infection model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335520     DOI: 10.1093/jac/31.suppl_d.177

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Pharmacodynamic parameters of aminoglycosides and their effect on exoenzymes of Pseudomonas aeruginosa.

Authors:  A Hostacká
Journal:  Folia Microbiol (Praha)       Date:  1996       Impact factor: 2.099

2.  In vivo efficacy of the novel aminoglycoside ACHN-490 in murine infection models.

Authors:  Noe Reyes; James B Aggen; Corwin F Kostrub
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

3.  Functional relationship between bacterial cell density and the efficacy of antibiotics.

Authors:  Klas I Udekwu; Nicholas Parrish; Peter Ankomah; Fernando Baquero; Bruce R Levin
Journal:  J Antimicrob Chemother       Date:  2009-02-13       Impact factor: 5.790

4.  Duration and clinical relevance of postantibiotic effect in relation to the dosing interval.

Authors:  J G den Hollander; K Fuursted; H A Verbrugh; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

5.  Classic reaction kinetics can explain complex patterns of antibiotic action.

Authors:  Pia Abel Zur Wiesch; Sören Abel; Spyridon Gkotzis; Paolo Ocampo; Jan Engelstädter; Trevor Hinkley; Carsten Magnus; Matthew K Waldor; Klas Udekwu; Ted Cohen
Journal:  Sci Transl Med       Date:  2015-05-13       Impact factor: 17.956

6.  Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli.

Authors:  F Fuentes; J Izquierdo; M M Martín; M L Gomez-Lus; J Prieto
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

7.  In vitro antibacterial activity of acyl-lysyl oligomers against Helicobacter pylori.

Authors:  Morris O Makobongo; Tchelet Kovachi; Hanan Gancz; Amram Mor; D Scott Merrell
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

8.  Different patterns of bacterial DNA synthesis during postantibiotic effect.

Authors:  M Gottfredsson; H Erlendsdóttir; A Gudmundsson; S Gudmundsson
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

9.  Dynamics of success and failure in phage and antibiotic therapy in experimental infections.

Authors:  J J Bull; Bruce R Levin; Terry DeRouin; Nina Walker; Craig A Bloch
Journal:  BMC Microbiol       Date:  2002-11-26       Impact factor: 3.605

10.  Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit.

Authors:  Berna Ozbek Celik; Emel Mataraci-Kara; Mesut Yilmaz
Journal:  Biomed Res Int       Date:  2014-10-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.